Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Bernstein

Showing results (141-150 of 379) with videos related to

Pageof 38
Sort By:
Pediatrics|January 24, 2019
Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young WomenChelse Spinner, Lili Ding, David I Bernstein, et al.
The Science of the Total Environment|October 20, 2006
The effect of home characteristics on dust antigen concentrations and loads in homesSeung-Hyun Cho, Tiina Reponen, David I Bernstein, et al.
Plos One|March 28, 2019
Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trialsDavid I Bernstein, Rhonda D Cardin, Derek A Pullum, et al.
Vaccine|September 16, 2022
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein GBrent A Stanfield, Fernando J Bravo, David A Dixon, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2019
Understanding differences in allergen immunotherapy products and practices in North America and EuropeVera Mahler, Robert E Esch, Jörg Kleine-Tebbe, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2019
ReplyVera Mahler, Robert E Esch, Jörg Kleine-Tebbe, et al.
Vaccine|November 26, 2018
The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpesDavid I Bernstein, Derek A Pullum, Rhonda D Cardin, et al.
Infection and Immunity|November 24, 2004
Acellular pertussis vaccines and complement killing of Bordetella pertussisAlison A Weiss, Angela K Patton, Scott H Millen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 17, 2026
Efficacy of epinephrine nasal spray in the treatment of urticariaDavid I Bernstein, Neetu Talreja, Thomas B Casale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 13, 2018
Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy TabletHendrik Nolte, David I Bernstein, Gordon L Sussman, et al.
Pageof 38

Showing results (141-150 of 379) with videos related to

Sort By:
Pageof 38
Pediatrics|January 24, 2019
Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young WomenChelse Spinner, Lili Ding, David I Bernstein, et al.
The Science of the Total Environment|October 20, 2006
The effect of home characteristics on dust antigen concentrations and loads in homesSeung-Hyun Cho, Tiina Reponen, David I Bernstein, et al.
Plos One|March 28, 2019
Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trialsDavid I Bernstein, Rhonda D Cardin, Derek A Pullum, et al.
Vaccine|September 16, 2022
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein GBrent A Stanfield, Fernando J Bravo, David A Dixon, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2019
Understanding differences in allergen immunotherapy products and practices in North America and EuropeVera Mahler, Robert E Esch, Jörg Kleine-Tebbe, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2019
ReplyVera Mahler, Robert E Esch, Jörg Kleine-Tebbe, et al.
Vaccine|November 26, 2018
The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpesDavid I Bernstein, Derek A Pullum, Rhonda D Cardin, et al.
Infection and Immunity|November 24, 2004
Acellular pertussis vaccines and complement killing of Bordetella pertussisAlison A Weiss, Angela K Patton, Scott H Millen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 17, 2026
Efficacy of epinephrine nasal spray in the treatment of urticariaDavid I Bernstein, Neetu Talreja, Thomas B Casale, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 13, 2018
Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy TabletHendrik Nolte, David I Bernstein, Gordon L Sussman, et al.
Pageof 38